SignalXSignalX

CME Group (CME) FY2024 10-K Annual Report

Filed: Feb 27, 2025
Financials
Security & Commodity Brokers, Dealers, Exchanges & ServicesSEC EDGAR
CME Group Overview

CME Group (CME) 10-K annual report for fiscal year 2024, filed with SEC EDGAR on Feb 27, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

CME Group FY2024 10-K Analysis

Business Overview

  • • Core business model: Global derivatives marketplace enabling trading across asset classes including futures and options
  • • No new products, services, or business segments introduced or emphasized in this filing year
+3 more insights

Management Discussion & Analysis

  • • Revenue $6.13B, up 10% YoY from $5.58B, driven by 9% volume growth in clearing and transaction fees
  • • Operating margin 64.1% vs 61.6%, net income $3.53B up 9% YoY
+3 more insights

Risk Factors

  • • Regulatory risk from failure to maintain BrokerTec Americas' FICC membership, requiring timely margin payments to avoid loss of customer trust and trading volumes
  • • Geopolitical exposure to regulatory changes in U.S., U.K., and E.U. jurisdictions impacting compliance costs and business structure globally
+3 more insights

CME Group FY2024 Key Financial Metrics
XBRL

Revenue

$6.1B

▲ +9.9% YoY

Net Income

$3.5B

▲ +9.3% YoY

Operating Margin

64.1%

▲ +255bp YoY

Net Margin

57.5%

▼ -31bp YoY

ROE

13.3%

▲ +125bp YoY

Total Assets

$137.4B

▲ +6.0% YoY

EPS (Diluted)

$9.67

▲ +9.1% YoY

Operating Cash Flow

$3.7B

▲ +6.9% YoY

Source: XBRL data from CME Group FY2024 10-K filing on SEC EDGAR. All figures in USD.

Other CME Group Annual Reports

FY2025 10-K

Get deeper insights on CME Group

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.